KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 153 filers reported holding KURA ONCOLOGY INC in Q4 2021. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $655,883 | +1048.9% | 53,629 | +1065.8% | 0.00% | – |
| Q4 2022 | $57,086 | -98.6% | 4,600 | -98.5% | 0.00% | -100.0% |
| Q3 2022 | $4,180,000 | +1717.4% | 306,037 | +2335.0% | 0.02% | +2300.0% |
| Q2 2022 | $230,000 | -18.1% | 12,568 | -28.0% | 0.00% | -50.0% |
| Q1 2022 | $281,000 | -66.9% | 17,447 | -71.2% | 0.00% | -75.0% |
| Q4 2021 | $850,000 | -41.1% | 60,682 | -21.3% | 0.01% | -55.6% |
| Q3 2021 | $1,444,000 | +5.2% | 77,102 | +17.1% | 0.02% | +20.0% |
| Q2 2021 | $1,373,000 | +74.7% | 65,831 | +173.4% | 0.02% | +36.4% |
| Q4 2020 | $786,000 | +7.7% | 24,075 | +1.0% | 0.01% | 0.0% |
| Q3 2020 | $730,000 | +436.8% | 23,834 | +186.0% | 0.01% | +450.0% |
| Q2 2020 | $136,000 | -37.0% | 8,333 | -46.9% | 0.00% | -50.0% |
| Q4 2019 | $216,000 | -7.7% | 15,684 | +31.8% | 0.00% | 0.0% |
| Q2 2019 | $234,000 | – | 11,898 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |